The blood-brain barrier (BBB) is located at the interface between the vascular system and
the brain parenchyma, and is responsible for communication with systemic circulation and …

Cerebral syndromes related to high-altitude exposure are becoming more frequent as the
number of trips to high altitudes has increased in the last decade. The commonest symptom …

Background: Minocycline, a second-generation tetracycline alleviates neuro-inflammation
and protects the blood–brain barrier (BBB) in ischemia stroke. However, the effect of …

High‐altitude cerebral oedema (HACE) is a potentially fatal manifestation of high‐altitude
sickness and is caused partly by inflammation and the blood–brain barrier disruption …

Acute mountain sickness (AMS) occurs in up to 25% of unacclimatized persons who ascend
to 3000 m and can result in high‐altitude pulmonary edema (HAPE). MicroRNAs (miRs) can …

High altitude cerebral edema (HACE) is a potentially life-threatening disease encountered at
high altitudes. However, effective methods for HACE prophylaxis are limited. Convincing …

With the increasing of altitude activities from low-altitude people, the study of high altitude
cerebral edema (HACE) has been revived. HACE is a severe acute mountain sickness …

High altitude cerebral edema (HACE) is a kind of life threat disease encountered at high
altitude, but the precise pathogenesis of it is far more understood. Hypobaic hypoxia (HH) …

Objectives Elevated optic nerve sheath diameter on sonography is known to correlate with
increased intracranial pressure and is observed in acute mountain sickness. This study …

Cerebral edema is a potentially life-threatening complication shared by diseases of different
etiology, such as diabetic ketoacidosis, acute liver failure, high altitude exposure, dialysis …